Scarica l'app Stockscreener
19.21
4.86%
0.89
Pre-mercato:
19.18
-0.03
-0.16%
Precedente Chiudi:
$18.32
Aprire:
$18.34
Volume 24 ore:
3.75M
Relative Volume:
1.06
Capitalizzazione di mercato:
$4.57B
Reddito:
$474.17M
Utile/perdita netta:
$208.93M
Rapporto P/E:
22.62
EPS:
0.8493
Flusso di cassa netto:
$65.61M
1 W Prestazione:
+22.43%
1M Prestazione:
+26.55%
6M Prestazione:
-5.93%
1 anno Prestazione:
-10.53%
Intervallo 1D:
$18.30
$19.22
Intervallo di 1 settimana:
$15.46
$19.22
Portata 52W:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Confronta ADMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
19.21 | 4.36B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
What's Driving the Market Sentiment Around ADMA Biologics Inc? - Benzinga
High Growth Tech Stocks In The US For November 2025 - Yahoo Finance
Is ADMA Biologics Inc a good long term investmentBollinger Bands Signals & Access Free Tools and Start Investing - earlytimes.in
Adma Biologics (ADMA) CEO Grossman sells $336k in shares By Investing.com - Investing.com South Africa
Adma Biologics (ADMA) CEO Grossman sells $336k in shares - Investing.com India
ADMA Biologics CEO Adam S Grossman Sells Shares - TradingView
[Form 4] ADMA BIOLOGICS, INC. Insider Trading Activity - Stock Titan
CEO Grossman Sells 21,000 ($336K) Of Adma Biologics Inc [ADMA] - TradingView
Trading the Move, Not the Narrative: (ADMA) Edition - news.stocktradersdaily.com
ADMA Biologics: Why The Dip To $16 Resets The Buy Case (NASDAQ:ADMA) - Seeking Alpha
Why ADMA Biologics Inc. stock appeals to analysts2025 Price Targets & Risk Controlled Daily Plans - newser.com
Building trade automation scripts for ADMA Biologics Inc.Earnings Growth Summary & Daily Technical Forecast Reports - newser.com
ADMA Biologics Inc (ADMA) Stock forecasts - Yahoo Finance UK
Will ADMA Biologics Inc. stock continue dividend increases2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com
Applying Wyckoff theory to ADMA Biologics Inc. stock2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - sharewise.com
ADMA Biologics Inc (ADMA) Stock Forecasts - Yahoo Finance
Risk adjusted return profile for ADMA Biologics Inc. analyzedJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
ADMA Biologics, Inc. (ADMA) Stock Price Quote Today & Current Price Chart - Capital.com
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - sharewise.com
ADMA Biologics Inc Stock Analysis and ForecastVolatility Adjusted Trading & Actionable Entry & Exit Points Daily - earlytimes.in
Why ADMA Biologics' (NASDAQ:ADMA) Earnings Are Weaker Than They Seem - Yahoo Finance
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade - sharewise.com
(ADMA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Adma Biologics Shares Maintain Upward Momentum on Strong Financial Performance - AD HOC NEWS
ADMA Biologics (ADMA) Is Down 8.1% After Raising Revenue Guidance Through 2029 Has The Bull Case Changed? - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2025 Earnings Call Transcript - Insider Monkey
ADMA Biologics Reports Strong Q3 2025 Financial Results - MSN
ADMA Biologics Inc earnings matched, revenue topped estimates By Investing.com - Investing.com Australia
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales - sharewise.com
ADMA Biologics Inc. Reports Strong Q3 Earnings Call - TipRanks
ADMA Biologics Ups Guidance After Outpacing Revenue Estimates - Finimize
ADMA Biologics (ADMA) Reports Record Revenue Growth in Q3 2025 - GuruFocus
ADMA Biologics Inc earnings matched, revenue topped estimates - Investing.com India
Adma Biologics: Q3 Earnings Snapshot - CT Insider
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):